Cryo-Cell International, Inc. (CCEL) Earnings History
Annual and quarterly earnings data from 1996 to 2024
Loading earnings history...
CCEL EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
CCEL Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2024 | 75.2% | 10.9% | 1.3% |
| 2023 | 73.1% | -39.3% | -30.4% |
| 2022 | 71.0% | 13.3% | 9.1% |
| 2021 | 68.9% | 13.9% | 7.2% |
| 2020 | 69.0% | 24.6% | 11.6% |
Download Data
Export CCEL earnings history in CSV or JSON format
Free sign-in required to download data
Cryo-Cell International, Inc. (CCEL) Earnings Overview
As of May 6, 2026, Cryo-Cell International, Inc. (CCEL) reported trailing twelve-month net income of $399,609, reflecting +104.4% year-over-year growth. The company earned $0.05 per diluted share over the past four quarters, with a net profit margin of 1.3%.
Looking at the long-term picture, CCEL's 5-year EPS compound annual growth rate (CAGR) stands at -28.6%, signaling declining earnings. The company achieved its highest annual net income of $8M in fiscal 2015.
Cryo-Cell International, Inc. maintains positive profitability with a gross margin of 75.2%, operating margin of 10.9%, and net margin of 1.3%. The company continues to generate positive earnings from operations. View revenue history →
Compared to peers including VCEL ($17M net income, 6.0% margin), BLFS (-$12M net income, -12.6% margin), IART (-$496M net income, -31.6% margin), CCEL has room to improve margins relative to the peer group. Compare CCEL vs VCEL →
CCEL Earnings vs Peers
Earnings metrics vs comparable public companies
CCEL Historical Earnings Data (1996–2024)
29 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | $402,095 | +104.2% | $3M | $0.05 | 1.3% | 10.9% |
| 2023 | -$10M | -443.6% | -$12M | $-1.14 | -30.4% | -39.3% |
| 2022 | $3M | +33.0% | $4M | $0.33 | 9.1% | 13.3% |
| 2021 | $2M | -42.5% | $4M | $0.25 | 7.2% | 13.9% |
| 2020 | $4M | +58.2% | $8M | $0.45 | 11.6% | 24.6% |
| 2019 | $2M | +368.0% | $5M | $0.27 | 7.2% | 15.9% |
| 2018 | $-854,824 | -136.9% | $5M | $-0.11 | -2.9% | 17.8% |
| 2017 | $2M | +275.3% | $5M | $0.30 | 9.1% | 19.7% |
| 2016 | -$1M | -116.3% | $433,594 | $-0.16 | -5.7% | 1.9% |
| 2015 | $8M | +1364.2% | $3M | $0.83 | 38.4% | 13.9% |
See CCEL's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs CCEL Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare CCEL vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonCCEL — Frequently Asked Questions
Quick answers to the most common questions about buying CCEL stock.
Is CCEL growing earnings?
CCEL EPS is $0.05, with earnings growth accelerating to +104.4%. This exceeds the 5-year CAGR of -28.6%. TTM net income reached $399609.00.
What are CCEL's profit margins?
Cryo-Cell International, Inc. net margin is +1.3%, with operating margin at +10.9%. Below-average margins reflect competitive or cost pressures.
How consistent are CCEL's earnings?
CCEL earnings data spans 1996-2024. The accelerating earnings trend is +104.4% YoY. Historical data enables comparison across business cycles.